The New Yorkerのインスタグラム(newyorkermag) - 7月22日 03時50分

Multiple sclerosis presents far more variously than most other illnesses. “If you have ever Googled a random tingling or twinge or eyebrow twitch, you have probably spent at least one evening convinced that you have M.S.,” Rivka Galchen writes. “On the other hand, M.S. patients often think for a while that they don’t have much going on.” One person’s first symptom might be numbness, while a different patient might present with an unexplained fall, or fatigue, or difficulty urinating or walking. Until recently, patients weren’t given medication before they were in distress; now treatment tends to come early, with the highest-efficacy drugs available.

In 2005, when one neurologist started her residency, “the field was still sometimes called ‘diagnose and adios,’ ” she said, “because it seemed like there was so little that could be done for patients with these chronic neurological diseases,” such as M.S., Parkinson’s, A.L.S., and Alzheimer’s. “M.S. is the only chronic neurological disease where there’s been a very dramatic change.” How did we learn so much, so quickly? At the link in our bio, Rivka Galchen explores the little interventions that have added up to remarkable progress—and what they could mean for how we study other conditions. Illustration by @juncenart.

[BIHAKUEN]UVシールド(UVShield)

>> 飲む日焼け止め！「UVシールド」を購入する